History
  • No items yet
midpage
Weisblum v. Prophase Labs, Inc.
88 F. Supp. 3d 283
S.D.N.Y.
2015
Read the full case

Background

  • Prophase Labs (Nevada corp., HQ Pennsylvania) and CEO Theodore Karkus market and sell Cold-EEZE (homeopathic cold remedies) nationally; packaging and ads represented Cold-EEZE as "clinically proven" to reduce duration and severity of colds.
  • Plaintiffs Eli Weisblum (purchased lozenges in NY) and James Gibbs (purchased lozenges in CA) allege reliance on those representations and seek to represent a consumer class.
  • Complaint asserts violations of New York and California consumer-protection laws, Magnuson-Moss Warranty Act (MMWA), express and implied warranty, unjust enrichment, negligent and fraudulent misrepresentation.
  • Defendants moved to dismiss for lack of personal jurisdiction (as to Gibbs’ claims against Prophase), lack of standing for products other than lozenges, and failure to state claims.
  • Court dismissed California claims against Prophase for lack of personal jurisdiction; allowed most New York claims and California claims against Karkus to proceed; dismissed certain counts (including implied warranty (NY), unjust enrichment (NY), negligent misrepresentation, and several California statutory claims as to Prophase).

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Personal jurisdiction over Prophase for Gibbs’ California claims Prophase answered original complaint and participated in case; therefore waived objection Prophase is not "at home" in NY and did not waive jurisdictional defenses Dismissed California claims against Prophase for lack of general jurisdiction; no jurisdictional discovery permitted
Standing for claims about non-lozenge Cold-EEZE products Named plaintiffs’ purchases suffice to assert class claims for other product forms Plaintiffs lack Article III standing for products they did not buy Article III standing satisfied at this stage; class standing issues reserved for certification
MMWA jurisdictional limits vs CAFA MMWA limits (individual <$25, <100 named plaintiffs) bar federal MMWA claims CAFA provides independent federal jurisdiction for qualifying class actions CAFA can supply subject-matter jurisdiction over MMWA claims where its prerequisites are met; MMWA claims allowed to proceed
Privity and warranty claims (express & implied) Plaintiffs relied on manufacturer advertising and inserts; privity not required for advertising-based claims Privity required under UCC for warranty claims Express warranty claims survive (NY & CA) where based on advertising; implied warranty claims dismissed for New York subclass (no privity); implied warranty claims survive as to California
Unjust enrichment (NY) Pleaded as alternative remedy for money paid because of deceptive marketing Claim duplicates contract/tort remedies and is not available NY unjust enrichment claim dismissed as duplicative
Negligent misrepresentation / economic loss rule Plaintiffs allege economic harms from deceptive marketing Economic loss doctrine bars tort recovery for purely economic loss Negligent misrepresentation dismissed (economic loss); intentional fraud survives (economic loss rule inapplicable to fraud allegations)
Claims against Karkus (reliance and CCLRA notice) Plaintiffs allege Karkus made personal guarantees in ads and inserts and they relied on them; Gibbs provided 30-day CCLRA notice Defendants argue plaintiffs could not have relied on personal guarantees; notice insufficient as it didn't name Karkus Claims against Karkus (express warranty, fraud, many CA statutory claims, GBL claims) survive; CCLRA notice adequate and reliance pled plausibly

Key Cases Cited

  • Kalnit v. Eichler, 264 F.3d 131 (2d Cir. 2001) (standard for pleading fraud with particularity and evaluating pleadings on motion)
  • Daimler AG v. Bauman, 571 U.S. 117 (2014) (limits on general jurisdiction; corporation "at home" generally only in state of incorporation or principal place of business)
  • Burger King Corp. v. Rudzewicz, 471 U.S. 462 (1985) (minimum contacts and purposeful availment analysis)
  • Twombly v. Bell Atl. Corp., 550 U.S. 544 (2007) (plausibility pleading standard)
  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (application of Twombly plausibility standard)
  • NECA-IBEW Health & Welfare Fund v. Goldman Sachs & Co., 693 F.3d 145 (2d Cir. 2012) (standing and differences between Article III standing and class standing)
Read the full case

Case Details

Case Name: Weisblum v. Prophase Labs, Inc.
Court Name: District Court, S.D. New York
Date Published: Feb 20, 2015
Citation: 88 F. Supp. 3d 283
Docket Number: No. 14-CV-3587 (JMF)
Court Abbreviation: S.D.N.Y.